Search

everythinglearnresearchcommunity

for

Search:↓

A new compound slows cancer cell growth and causes cell death by blocking cell cycle progression and increasing cell-damaging molecules.

A new microneedle patch significantly improves melanoma treatment by using a special material to activate cancer-fighting drugs and disrupt cancer cells.

PPARγ signaling modulation can protect hair follicle stem cells from chemotherapy-induced damage.

Targeting EGFR may help reduce hair loss from chemotherapy.

A woman experienced severe side effects from a drug due to a specific genetic variation, suggesting genetic testing could prevent such risks.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Topoisomerase inhibitors can cause hair loss, skin rash, hand-foot syndrome, and nail changes.

N-acetylcysteine may prevent hair loss caused by chemotherapy.

DS-2325a is safe and well-tolerated, supporting further development for Netherton Syndrome treatment.

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

Cytarabine can cause multiple organ toxicities, especially neurotoxicity, but better research methods are needed to fully understand and predict these effects.

Docetaxel is effective against various cancers but mainly causes neutropenia.

Mycophenolate mofetil improved skin condition in a man with nephrogenic fibrosing dermopathy.

Deleting the EDAR gene in Cashmere goats affects genes and proteins related to hair growth.

N13-substituted evodiamine derivatives improved anticancer activity and solubility, showing promise for drug development.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Golvatinib shows promise as a treatment for Omicron in elderly patients.

Anthracycline and taxane chemotherapy cause significant side effects like fatigue, vomiting, nausea, nerve damage, joint pain, and hair loss in breast cancer patients.

Topical thiols may prevent hair loss caused by certain chemotherapy drugs.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

M30 is a promising treatment for preventing hair loss during chemotherapy.

Axitinib treatment turned a man's grey hair back to black.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

The review suggests that while many AKR1C3 inhibitors show promise for treating certain cancers, more research is needed to confirm their effectiveness in humans.

Imatinib can repigment grey hair, while SU11428 can cause temporary hair depigmentation.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

The study concludes that the EDA2R gene is activated by p53 during chemotherapy but is not necessary for chemotherapy-induced hair loss.